Cargando…

Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study

Detalles Bibliográficos
Autores principales:	Ceraulo, Antony, Lapillonne, Hélène, Cheok, Meyling H, Preudhomme, Claude, Dombret, Hervé, Terré, Christine, Lambert, Juliette, Leverger, Guy, Bertrand, Yves, Mortreux, Franck, Wattel, Eric
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Hematology 2022
Materias:	Research Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092411/ https://www.ncbi.nlm.nih.gov/pubmed/35008099 http://dx.doi.org/10.1182/bloodadvances.2021006040

Ejemplares similares

Germline pathogenic variants in transcription factors predisposing to pediatric acute myeloid leukemia: results from the French ELAM02 trial
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Prognostic impact of RUNX1 mutations and deletions in pediatric acute myeloid leukemia: results from the French ELAM02 study group
por: Lew-Derivry, Lucille, et al.
Publicado: (2023)

Molecular Profiling Defines Distinct Prognostic Subgroups in Childhood AML: A Report From the French ELAM02 Study Group
por: Marceau-Renaut, Alice, et al.
Publicado: (2018)

Maintenance Therapy With Interleukin-2 for Childhood AML: Results of ELAM02 Phase III Randomized Trial
por: Petit, Arnaud, et al.
Publicado: (2018)

Leukemia Cutis in Childhood Acute Myeloid Leukemia: Epidemiological, Clinical, Biological, and Prognostic Characteristics of Patients Included in the ELAM02 Study
por: Gouache, Elodie, et al.
Publicado: (2018)

LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
por: Vasseur, Loïc, et al.
Publicado: (2023)

Is Acute Myeloblastic Leukemia in Children Under 2 Years of Age a Specific Entity? A Report from the FRENCH ELAM02 Study Group
por: Blais, S., et al.
Publicado: (2019)

Clinical impact of gene mutations and lesions detected by SNP-array karyotyping in acute myeloid leukemia patients in the context of gemtuzumab ozogamicin treatment: Results of the ALFA-0701 trial
por: Renneville, Aline, et al.
Publicado: (2014)

Biomarkers of Gemtuzumab Ozogamicin Response for Acute Myeloid Leukemia Treatment
por: Fenwarth, Laurène, et al.
Publicado: (2020)

Elam on Cerebria
Publicado: (1873)

2nd ELAM Conference
por: Bott, R, et al.
Publicado: (1972)

A 17-gene-expression profile to improve prognosis prediction in childhood acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Gemtuzumab ozogamicin for de novo acute myeloid leukemia: final efficacy and safety updates from the open-label, phase III ALFA-0701 trial
por: Lambert, Juliette, et al.
Publicado: (2019)

SNP-array lesions in core binding factor acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2018)

Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group
por: Ferret, Yann, et al.
Publicado: (2018)

MRD assessed by WT1 and NPM1 transcript levels identifies distinct outcomes in AML patients and is influenced by gemtuzumab ozogamicin
por: Lambert, Juliette, et al.
Publicado: (2014)

Clofarabine Improves Relapse-Free Survival of Acute Myeloid Leukemia in Younger Adults with Micro-Complex Karyotype
por: Fenwarth, Laurène, et al.
Publicado: (2019)

Oncogene- and drug resistance-associated alternative exon usage in acute myeloid leukemia (AML)
por: Mohamed, Aminetou Mint, et al.
Publicado: (2015)

Cause-specific telomere factors deregulation in hepatocellular carcinoma
por: El Idrissi, Manale, et al.
Publicado: (2013)

Cloned HTLV-1+CD4+, but not CD8+, T-cells display an oncogenic miRNome
por: Vernin, Céline, et al.
Publicado: (2011)

How mRNA is misspliced in acute myelogenous leukemia (AML)?
por: Mohamed, Aminetou Mint, et al.
Publicado: (2014)

The effects of platelet activating factor and retinoic acid on the expression of ELAM-1 and ICAM-1 and the functions of neutrophils
por: Chen, Si-Feng
Publicado: (1995)

Clinical Significance of ABCB1 in Acute Myeloid Leukemia: A Comprehensive Study
por: Boyer, Thomas, et al.
Publicado: (2019)

Impact of CNA on AML prognosis
por: Gonzales, Fanny, et al.
Publicado: (2017)

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia
por: Boyer, Thomas, et al.
Publicado: (2016)

Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
por: Lambert, Juliette, et al.
Publicado: (2021)

The HTLV-1 encoded bZIP factor promotes cell proliferation and genetic instability through activation of oncogenic microRNAs
por: Vernin, Céline, et al.
Publicado: (2014)

Tax alters telomerase activity through both quantitative and qualitative hTERT transcriptional dysregulations
por: Karam, Maroun, et al.
Publicado: (2011)

HTLV-1 modulates alternative splicing in CD4+ T cells in vivo
por: Thenoz, Morgan, et al.
Publicado: (2011)

IDH1/2 but not DNMT3A mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French Association
por: Debarri, Houria, et al.
Publicado: (2015)

Early and transient reverse transcription during primary deltaretroviral infection of sheep
por: Pomier, Carole, et al.
Publicado: (2008)

UBTF tandem duplications define a distinct subtype of adult de novo acute myeloid leukemia
por: Duployez, Nicolas, et al.
Publicado: (2023)

A dose-effect relationship for deltaretrovirus-dependent leukemogenesis in sheep
por: Pomier, Carole, et al.
Publicado: (2009)

Tax promotes the expression of the alternative spliced isoform CD44v10 by slowing down the elongating RNA polymerase II
por: Thenoz, Morgan, et al.
Publicado: (2014)

Alternative splicing signatures discriminate ATL cells from untransformed CD4+ counterparts deriving from HTLV-1 infected individuals
por: Thenoz, Morgan, et al.
Publicado: (2014)

Tax gene expression and cell cycling but not cell death are selected during HTLV-1 infection in vivo
por: Zane, Linda, et al.
Publicado: (2010)

HTLV-1-infected CD4+ T-cells display alternative exon usages that culminate in adult T-cell leukemia
por: Thénoz, Morgan, et al.
Publicado: (2014)

Germline RUNX1 variants in paediatric patients in a French specialised centre
por: Liu, Cécile, et al.
Publicado: (2022)

ALFA
por: Hiller, Karlheinz
Publicado: (2012)

MPAgenomics: an R package for multi-patient analysis of genomic markers
por: Grimonprez, Quentin, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_j9237us8j2vivcgi8di05n38me